Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
HIV Medicine|August 25, 2016
Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration - a comprehensive meeting reportJ D Kowalska, C Oprea, S de Witt, et al.
The British Journal of Dermatology|June 1, 1996
Use of terbinafine in HIV-positive subjects: pilot studies in onychomycosis and oral candidiasisR Nandwani, A Parnell, M Youle, et al.
AIDS (London, England)|May 1, 1996
Randomized cross-over comparison of liposomal daunorubicin versus observation for early Kaposi's sarcomaS Uthayakumar, M Bower, J Money-Kyrle, et al.
AIDS (London, England)|June 16, 2001
Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatmentW Schrooten, R Colebunders, M Youle, et al.
Sexually Transmitted Infections|January 5, 2000
Poor reduction of HIV-1 RNA titres in nucleoside reverse transcriptase inhibitor experienced patients treated with indinavir combination therapyJ K Ball, T Rowe, R Curran, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1988
Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndromeA Karpas, F Hill, M Youle, et al.
HIV Medicine|December 12, 2001
Changing treatment patterns among patients with HIV: Royal Free Hospital 1987-97A Mocroft, C A Sabin, M Youle, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID miceP S Sarin, C A Mora, P H Naylor, et al.
The Journal of Antimicrobial Chemotherapy|July 1, 2008
Long-term clinical and surrogate marker effects of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patientsC Herzmann, Z Cuthbertson, L Fosdick, et al.
HIV Medicine|December 12, 2001
Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 yearsS Madge, A Mocroft, D Wilson, et al.
Pageof 8